A 28-year-old primigravida with a singleton viable fetus and oligohydramnios on ultrasound—what is the most likely cause: chorioangioma, duodenal atresia, diabetes mellitus, or placental insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Placental Insufficiency is the Most Likely Cause

In a 28-year-old primigravida with isolated oligohydramnios on ultrasound, placental insufficiency is the most likely diagnosis among the options provided.

Rationale for Placental Insufficiency (Answer D)

Placental insufficiency represents the most common pathophysiologic mechanism for oligohydramnios in singleton pregnancies without obvious fetal anomalies 1, 2. The key supporting evidence includes:

  • Uteroplacental insufficiency is a well-established cause of oligohydramnios, often manifesting through fetal growth restriction, postdates pregnancy, or maternal vascular disease 3, 4
  • Placental under-perfusion directly correlates with reduced amniotic fluid volume through decreased fetal renal perfusion and subsequent reduced urine production 5
  • Oligohydramnios independently increases stillbirth risk 2.6-fold, reflecting the severity of placental dysfunction 6, 1, 2

Why the Other Options Are Less Likely

Chorioangioma (Option A) - Incorrect

  • Chorioangiomas are rare placental tumors that typically cause polyhydramnios, not oligohydramnios 7
  • When complications occur, they include polyhydramnios (most common), fetal growth restriction, and nonimmune hydrops 7
  • Only 2 of 9 singleton cases with chorioangioma demonstrated oligohydramnios in one series, and these were associated with concurrent growth restriction (suggesting placental insufficiency as the mechanism) 7

Duodenal Atresia (Option B) - Incorrect

  • Duodenal atresia is a gastrointestinal obstruction that classically presents with polyhydramnios, not oligohydramnios, due to impaired fetal swallowing and absorption of amniotic fluid
  • While congenital anomalies can cause oligohydramnios, these are primarily genitourinary malformations (renal agenesis, severe dysplasia, or obstructive uropathy) that prevent fetal urine production 2, 3, 4

Diabetes Mellitus (Option C) - Incorrect

  • Maternal diabetes is associated with polyhydramnios, not oligohydramnios 6
  • Polyhydramnios occurs in diabetic pregnancies due to fetal polyuria from hyperglycemia
  • While diabetes can cause placental insufficiency in advanced vascular disease, this would be the mechanism rather than diabetes itself being the direct cause

Clinical Approach to This Patient

Immediate evaluation should include:

  • Detailed fetal biometry to assess for growth restriction, as oligohydramnios with IUGR indicates placental insufficiency and warrants delivery at 34-37 weeks depending on Doppler findings 1, 2
  • Umbilical artery Doppler velocimetry to evaluate placental resistance, as abnormal Doppler with oligohydramnios predicts adverse outcomes and guides delivery timing 6, 1
  • Comprehensive anatomic survey focusing on the genitourinary system to exclude renal anomalies as an alternative cause 3
  • Maternal evaluation for hypertension, preeclampsia, or other vascular disease that could cause placental insufficiency 3

Surveillance strategy:

  • Intensive antenatal testing with biophysical profile or modified BPP should begin immediately given the 2.6-fold increased stillbirth risk 6, 1
  • Frequency should be twice-weekly to weekly depending on severity and associated findings 1

Critical Pitfall to Avoid

Do not assume isolated oligohydramnios is benign even without growth restriction—the independent 2.6-fold increased stillbirth risk necessitates intensive surveillance regardless of fetal size 6, 1, 2.

References

Guideline

Management of Oligohydramnios in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Oligohydramnios in Pregnancy: Causes and Clinical Implications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oligohydramnios: problems and treatment.

Seminars in perinatology, 1993

Research

Oligohydramnios: a review.

Obstetrical & gynecological survey, 1991

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.